Publications by authors named "Anna Jirovec"

Claim this Profile
E
Efficacy, effectiveness and immunogenicity of reduced HPV vaccination schedules: A review of available evidence.
Joshua Montroy, Marina I Salvadori, Nicole Forbes, Vinita Dubey, Sarah Almasri, Anna Jirovec

Can Commun Dis Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune profiling of dedifferentiated liposarcoma and identification of novel antigens for targeted immunotherapy.
Anna Jirovec, Ashley Flaman, Elena Godbout, Daniel Serrano, Joel Werier

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy.
Boaz Wong, Anabel Bergeron, Glib Maznyi, Kristy Ng, Anna Jirovec

Mol Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines.
Nouf Alluqmani, Anna Jirovec, Zaid Taha, Oliver Varette, Andrew Chen

Front Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.
Mathieu J F Crupi, Zaid Taha, Thijs J A Janssen, Julia Petryk, Stephen Boulton, Anna Jirovec

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen.
Zaid Taha, Rozanne Arulanandam, Glib Maznyi, Elena Godbout, Madalina E Carter-Timofte, Anna Jirovec

Mol Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for sarcomas: new frontiers and unveiled opportunities.
Harsimrat Kaur Birdi, Anna Jirovec, Serena Cortés-Kaplan, Joel Werier, Carolyn Nessim

J Immunother Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy.
Fanny Tzelepis, Harsimrat Kaur Birdi, Anna Jirovec, Silvia Boscardin, Christiano Tanese de Souza

Mol Ther Oncolytics· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy.
Rozanne Arulanandam, Zaid Taha, Vanessa Garcia, Mohammed Selman, Andrew Chen, Anna Jirovec

Commun Biol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming the prostatic tumor microenvironment with oncolytic virotherapy.
Matthew J Atherton, Kyle B Stephenson, Fanny Tzelepis, David Bakhshinyan, Jake K Nikota, Anna Jirovec

Oncoimmunology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis